Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,436 public trials 1,999 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Completed

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

NCT01945775

Conditions
BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Diseases, +5 more
Locations
  • Arizona Oncology Associates P.C. - NAHOA Flagstaff, Arizona, United States
  • HonorHealth Scottsdale, Arizona, United States
  • Virginia G. Piper Cancer Pharmacy Scottsdale, Arizona, United States
  • Kaiser Permanente Medical Center Lab Drawing Station Antioch, California, United States
View all 362 locations
View Trial Details
Completed

Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate

NCT02600923

Conditions
Advanced Breast Cancer Female, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Instituto de Oncologia de Rosario Rosario, Santa Fe Province, Argentina
  • Sanatorio Guemes CABA, Argentina
  • Hospital Italiano de Buenos Aires CABA, Argentina
  • Hospital Britanico de Buenos Aires CABA, Argentina
View all 24 locations
View Trial Details
Completed

Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens

NCT02418689

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Chungbuk National University Hospital Cheongju-si, North Chungcheong, South Korea
  • Samsung Medical Center Gangnam-gu, Seoul, South Korea
View Trial Details
Completed

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

NCT03556358

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Tanvex Investigational Site 1008 Lyasny, Minsk Oblast, Belarus
  • Tanvex Investigational Site 1007 Babruysk, Mogilyov Oblast, Belarus
  • Tanvex Investigational Site 1006 Grodno, Belarus
  • Tanvex Investigational Site 1003 Homyel, Belarus
View all 146 locations
View Trial Details
Completed

A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer

NCT02296801

Conditions
Breast Cancer, Breast Carcinoma, Breast Diseases, +6 more
Locations
  • Long Beach Memorial Medical Center-Todd Cancer Institute Long Beach, California, United States
  • University of Miami Hospital and Clinics - Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Cancer Care Specialists of Central Illinois Decatur, Illinois, United States
  • Norton Healthcare Pavillion Louisville, Kentucky, United States
View all 52 locations
View Trial Details
Completed

Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer

NCT02482753

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The 307th Hospital of Chinese people's Liberation Army Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 22 locations
View Trial Details

Related conditions